X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2355) 2355
Book Review (378) 378
Publication (245) 245
Magazine Article (70) 70
Conference Proceeding (40) 40
Government Document (27) 27
Book Chapter (24) 24
Dissertation (15) 15
Newspaper Article (10) 10
Book / eBook (3) 3
Paper (1) 1
Report (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
mgmt (1590) 1590
index medicus (1455) 1455
humans (1299) 1299
oncology (988) 988
temozolomide (842) 842
glioblastoma (777) 777
male (642) 642
female (638) 638
dna methylation (628) 628
methylation (553) 553
middle aged (552) 552
cancer (516) 516
adult (491) 491
aged (451) 451
prognosis (442) 442
clinical neurology (420) 420
dna modification methylases - genetics (420) 420
tumor suppressor proteins - genetics (419) 419
dna repair enzymes - genetics (415) 415
mgmt promoter methylation (387) 387
chemotherapy (383) 383
brain neoplasms - genetics (378) 378
dacarbazine - analogs & derivatives (367) 367
gliomas (332) 332
tumors (328) 328
glioma (326) 326
radiotherapy (318) 318
o-6-methylguanine-dna methyltransferase (309) 309
survival (309) 309
expression (284) 284
glioblastoma multiforme (284) 284
glioblastoma - genetics (259) 259
promoter regions, genetic (256) 256
brain neoplasms - pathology (254) 254
medicine & public health (254) 254
dna repair (251) 251
promoter methylation (233) 233
o6-methylguanine-dna methyltransferase (229) 229
mutation (224) 224
dacarbazine - therapeutic use (217) 217
animals (216) 216
brain neoplasms - drug therapy (215) 215
analysis (211) 211
adjuvant temozolomide (206) 206
hypermethylation (202) 202
dna (200) 200
immunohistochemistry (199) 199
malignant glioma (199) 199
pathology (198) 198
neoplasms (197) 197
o-6-alkylguanine-dna alkyltransferase (196) 196
tumor suppressor proteins - metabolism (191) 191
dna modification methylases - metabolism (187) 187
genetic aspects (187) 187
dna repair enzymes - metabolism (186) 186
antineoplastic agents, alkylating - therapeutic use (178) 178
glioblastoma - pathology (178) 178
surgery (178) 178
o-methylguanine-dna methyltransferase - genetics (176) 176
glioblastoma - drug therapy (175) 175
aged, 80 and over (173) 173
deoxyribonucleic acid--dna (171) 171
neurosciences (168) 168
newly-diagnosed glioblastoma (168) 168
research (166) 166
cell line, tumor (165) 165
brain neoplasms - mortality (160) 160
neurology (160) 160
brain neoplasms - therapy (156) 156
promoter hypermethylation (155) 155
young adult (155) 155
care and treatment (154) 154
biomarkers, tumor - genetics (150) 150
gene expression (150) 150
treatment outcome (149) 149
gene (147) 147
glioma - genetics (147) 147
cell biology (146) 146
genetics & heredity (146) 146
alkylating-agents (142) 142
apoptosis (141) 141
brain tumors (141) 141
transferases (141) 141
biochemistry & molecular biology (140) 140
promoter regions, genetic - genetics (140) 140
inactivation (136) 136
adolescent (132) 132
glioblastoma - mortality (132) 132
o-methylguanine-dna methyltransferase - metabolism (131) 131
retrospective studies (129) 129
repair (128) 128
disease-free survival (125) 125
genes (124) 124
mgmt gene (123) 123
brain neoplasms - metabolism (121) 121
glioma - pathology (121) 121
polymerase chain reaction (120) 120
phase-ii trial (119) 119
brain cancer (118) 118
dna methyltransferase (118) 118
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2449) 2449
French (25) 25
German (20) 20
Chinese (12) 12
Japanese (8) 8
Korean (6) 6
Russian (3) 3
Spanish (3) 3
Czech (2) 2
Polish (2) 2
Croatian (1) 1
Hungarian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Acta neuropathologica, ISSN 0001-6322, 2015, Volume 129, Issue 4, pp. 597 - 607
Journal Article
Annals of oncology, ISSN 0923-7534, 2015, Volume 26, Issue 9, pp. 1994 - 1999
Journal Article
Modern Pathology, ISSN 0893-3952, 12/2009, Volume 22, Issue 12, pp. 1588 - 1599
Journal Article
Neurosurgical Review, ISSN 0344-5607, 2019
The promoter methylation status of the O -methylguanine-DNA methyltransferase (MGMT) gene has been described as the most important predictor of... 
ADC | Texture analysis | MGMT | Glioblastoma
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 12/2018, Volume 158, pp. 327 - 338
-Methylguanine-DNA methyltransferase (MGMT) is a DNA repair enzyme that removes the alkyl groups from the position of guanine and is then degraded via... 
Ubiquitination | UBE2B | MGMT | BCNU | Index Medicus
Journal Article
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, ISSN 0304-419X, 08/2012, Volume 1826, Issue 1, pp. 71 - 82
Journal Article
Cancer, ISSN 0008-543X, 07/2016, Volume 122, Issue 14, pp. 2206 - 2215
Journal Article
by Cheng, G and Xin, Q and Li, K and Sun, Ch and Lin, Zh and Luan, Y and Wang, J and Qi, T and Chen, Yu and Xu, D and Kong, F
Russian Journal of Genetics, ISSN 1022-7954, 04/2018, Volume 54, Issue 4, pp. 494 - 497
Journal Article
Experimental Cell Research, ISSN 0014-4827, 05/2016, Volume 343, Issue 2, pp. 148 - 158
The aim of this study was to investigate the effect of downregulation of α gene on human U251 glioma cells and examine the consequent changes of TMZ induced... 
Notch1 pathway | Brain glioma | O6-methylguanine DNA methyltransferase (MGMT) | HIF-1α | Temozolomide | Drug resistance | methylguanine DNA methyltransferase (MGMT) | O-6-methylguanine DNA methyltransferase (MGMT) | HIF-1 alpha | STABILITY | MGMT EXPRESSION | HYDROXYLATION | NOTCH | HYPOXIA | CANCER STEM-CELLS | CELL BIOLOGY | ONCOLOGY | RESISTANCE | HIF-1-ALPHA | CONTRIBUTES | GLIOBLASTOMA CELLS | Apoptosis - drug effects | Dacarbazine - therapeutic use | Humans | Brain Neoplasms - pathology | Neoplasm Proteins - metabolism | Glioma - genetics | Transfection | Dacarbazine - pharmacology | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Glioma - pathology | Dacarbazine - analogs & derivatives | Gene Expression Regulation, Neoplastic - drug effects | Hypoxia-Inducible Factor 1, alpha Subunit - genetics | Neoplasm Invasiveness | Brain Neoplasms - genetics | Brain Neoplasms - drug therapy | Down-Regulation - drug effects | Down-Regulation - genetics | Cell Movement - drug effects | Signal Transduction - drug effects | Cell Differentiation - drug effects | Cell Line, Tumor | Cell Proliferation - drug effects | Glioma - drug therapy | RNA, Small Interfering - metabolism | Antimitotic agents | Nervous system diseases | Antineoplastic agents | Gliomas | Brain tumors | Transferases | Studies | Cellular biology | Genes | Deoxyribonucleic acid--DNA | Index Medicus | APOPTOSIS | DMSO | BLOOD-BRAIN BARRIER | 60 APPLIED LIFE SCIENCES | BROMIDES | TETRAZOLIUM | SKELETON | REPAIR | POLYMERASE CHAIN REACTION | MESSENGER-RNA | ESTERS | GENES | GUANINE | BRAIN | BLOOD | GLIOMAS | GLYCINE | COLONY FORMATION | CELL PROLIFERATION | HEALING | ANOXIA | DNA | WOUNDS | STEM CELLS | MAGNESIUM OXIDES
Journal Article
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 6/2017, Volume 133, Issue 2, pp. 399 - 407
Journal Article
Immunologic Research, ISSN 0257-277X, 7/2009, Volume 44, Issue 1, pp. 112 - 126
Current approaches for hematopoietic stem cell (HSC) and organ transplantation are limited by donor and host-mediated immune responses to allo-antigens.... 
Major histocompatibility complex (MHC) | O 6 -methylguanine-DNA-methyltransferase (MGMT) | Internal Medicine | Human leukocyte antigen (HLA) | Medicine/Public Health, general | Lentivirus | Allergology | Busulfan (BU) | RNA interference (RNAi) | MGMT P140K -2A-GFP lentivirus vector (MAG) | Immunology | 1,3-bis(2-chloroethyl)-1-nitroso-urea (BCNU) | Medicine & Public Health | Benzylguanine (BG) | Short hairpin-type RNAi (shRNA) | MGMT | 2A-GFP lentivirus vector (MAG) | methylguanine- DNA-methyltransferase (MGMT) | UNRELATED DONOR | O-6-methylguanine-DNA-methyltransferase (MGMT) | CHEMOPROTECTION | TRANSDUCTION | IMMUNOLOGY | LARGE-ANIMAL MODEL | THERAPY | BONE-MARROW TRANSPLANTATION | MGMT(P140K)-2A-GFP lentivirus vector (MAG) | SELECTION | DRUG-RESISTANCE GENE | RETROVIRAL VECTOR | LYMPHOCYTES | Hematopoietic Stem Cells - drug effects | Gene Transfer Techniques | RNA, Small Interfering - genetics | DNA Modification Methylases - metabolism | Humans | Gene Silencing | Histocompatibility Antigens Class I - immunology | Histocompatibility Antigens Class I - genetics | Carmustine - pharmacology | Gene Knockdown Techniques | Hematopoietic Stem Cells - immunology | Animals | Transfection | Mice | Hematopoietic Stem Cell Transplantation - methods | Genetic Vectors | Immunohistochemistry | Leucocytes | Transplants & implants | Ribonucleic acid--RNA | Stem cells | Index Medicus | RNAi – RNA interference | MAG - MGMTP140K-2A-GFP lentivirus vector | MGMT - O6-methylguanine-DNA-methyltransferase | BU - Busulfan | BG - Benzylguanine | BCNU - 1,3-bis(2-chloroethyl1-nitrosourea) | MHC – Major Histocompability Complex | shRNA - short hairpin-type RNAi | HLA – Human Leukocyte Antigen
Journal Article
Journal Article